Baker Ellis Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,421
Closed -$189K 243
2019
Q3
$189K Hold
1,421
0.05% 177
2019
Q2
$162K Hold
1,421
0.04% 190
2019
Q1
$176K Hold
1,421
0.05% 172
2018
Q4
$143K Hold
1,421
0.04% 179
2018
Q3
$181K Hold
1,421
0.05% 190
2018
Q2
$154K Hold
1,421
0.04% 203
2018
Q1
$150K Hold
1,421
0.04% 201
2017
Q4
$167K Sell
1,421
-103
-7% -$11.6K 0.04% 197
2017
Q3
$173K Hold
1,524
0.05% 199
2017
Q2
$190K Hold
1,524
0.05% 193
2017
Q1
$181K Buy
1,524
+103
+7% +$11.7K 0.05% 198
2016
Q4
$142K Hold
1,421
0.04% 214
2016
Q3
$179K Hold
1,421
0.05% 200
2016
Q2
$166K Hold
1,421
0.05% 200
2016
Q1
$147K Hold
1,421
0.05% 206
2015
Q4
$142K Hold
1,421
0.05% 216
2015
Q3
$130K Hold
1,421
0.05% 225
2015
Q2
$151K Hold
1,421
0.05% 220
2015
Q1
$162K Hold
1,421
0.05% 219
2014
Q4
$157K Hold
1,421
0.05% 212
2014
Q3
$139K Hold
1,421
0.05% 224
2014
Q2
$143K Hold
1,421
0.05% 235
2014
Q1
$131K Hold
1,421
0.05% 240
2013
Q4
$129K Hold
1,421
0.04% 233
2013
Q3
$113K Hold
1,421
0.04% 237
2013
Q2
$103K Buy
+1,421
New +$106K 0.04% 239

Other funds holding ZBH

Baker Ellis Asset Management's ZBH Position: Q4 2019 in Review

Baker Ellis Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2019, closing a stake of 1,421 shares — an estimated $189K sold.

Baker Ellis Asset Management first reported a position in ZBH in Q2 2013 and held it in 26 quarters. The position peaked at $190K in Q2 2017. 989 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

  • Baker Ellis Asset Management reported no remaining Zimmer Biomet position as of Q4 2019 after selling out during the quarter.
  • Baker Ellis Asset Management sold 1,421 Zimmer Biomet shares in Q4 2019, an estimated $189K.
  • Baker Ellis Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 26 quarters.
  • Baker Ellis Asset Management's Zimmer Biomet position peaked at $190K in Q2 2017.
  • 989 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on Baker Ellis Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.